Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus
about
Clearance Deficiency and Cell Death Pathways: A Model for the Pathogenesis of SLETargeting C-Reactive Protein in Inflammatory Disease by Preventing Conformational ChangesPentraxins: structure, function, and role in inflammationSerum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritisThe complex nature of serum C3 and C4 as biomarkers of lupus renal flare.Protective molecules and their cognate antibodies: new players in autoimmunityCould antibodies to C-reactive protein link inflammation and cardiovascular disease in patients with systemic lupus erythematosus?Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-upCRP and the disposal of dying cells: consequences for systemic lupus erythematosus and rheumatoid arthritis.Increased expression of FcgammaRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus.The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.The search for lupus biomarkers.Anti-C reactive protein antibodies in Indian patients with systemic lupus erythematosus.Tubulointerstitial nephritis with uveitis in Chinese adultsHigh-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus.C-reactive protein in rheumatology: biology and genetics.Promising biomarkers for systemic lupus erythematosus.C-reactive protein and inflammation: conformational changes affect function.Is there still a place for erythrocyte sedimentation rate and C-reactive protein in systemic lupus erythematosus?The relationship between anti-C-reactive protein and disease activity in patients with systemic lupus erythematosus.Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis.Distinguishing infections vs flares in patients with systemic lupus erythematosus.Anti-pentraxin antibodies in autoimmune systemic diseases: Focus on anti-pentraxin-3 autoantibodies.Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction.Relationships between biomarkers of inflammation, ovarian steroids, and age at menarche in a rural Polish sample.Patients with unstable angina pectoris show an increased frequency of the Fc gamma RIIa R131 allele.Tubulointerstitial nephritis and uveitis.C-reactive protein +1444CT (rs1130864) genetic polymorphism is associated with the susceptibility to systemic lupus erythematosus and C-reactive protein levels.Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.Naturally occurring antibodies against serum amyloid A reduce IL-6 release from peripheral blood mononuclear cells.The value of decreased plasma gelsolin levels in patients with systemic lupus erythematosus and rheumatoid arthritis in diagnosis and disease activity evaluation.
P2860
Q26767511-7B31567A-CDD5-49D6-8728-E02820F8F7C9Q26999377-26CDF008-68FB-489F-AE45-88A449EC15E9Q28676262-00553636-F894-4B9E-B552-F69018AD10D4Q34413203-8F2DF9A7-A32B-41F2-A7B7-B042C972FDB7Q34905729-5D956085-D4AD-4EAE-A1C8-49FEB48860A8Q35309510-5F54C31D-5725-464E-8550-47364FC24709Q35953555-8CAA4A4D-D182-4E97-B171-4E543655DF6CQ36477390-4DC14B20-1221-4F28-9865-AAA893B56803Q36827942-1823E524-8329-444A-9B0F-91FF9B3634E7Q37207056-ACF1E23F-8B7D-4A15-BA6C-EC67FE92F5A6Q37233964-A4FF10AF-2464-4075-B770-D6967C9F7255Q37308042-B0233A40-71B8-4B6B-ACDE-1A4EB2C97FA7Q37345306-C3FB38DD-18BC-46D4-87A5-A281B0061D97Q37426941-6D6292D5-CB07-4F9E-AB54-92FAA587F3F6Q37857555-12DB9F1D-12E5-49C8-994F-697687EA0B60Q37862080-59D01147-9ED3-4A1F-A67B-A08AF7D7042CQ38149960-37E94012-B23E-40EA-AAB9-BA5964FAE773Q38514723-5746F5FE-0C5A-479E-9C68-30642409D934Q38852129-9340CB5D-4FA6-48B8-8312-531ADA25AFFBQ38870221-A692B0C6-C272-4793-8309-26549143596AQ38926368-BBD4F3EB-18EB-4F0E-A9B7-62C26825D91FQ38981689-D337FB01-185A-4EBA-83EF-F1BC623A77EFQ39283041-CF997DC4-807B-4D71-8B02-7F678A01F2AFQ39314024-E47BCDF7-0060-4387-93B2-AC3BADBF426EQ43724461-45D3C4DE-2F1E-40D0-99EB-9C29CD877ADDQ47808365-F937672F-418C-4C74-9AD9-2E9923368763Q47955949-A37179CA-4415-4CCB-A887-4E59A8D1ABB8Q50966748-40363AD0-343A-4278-A788-169169649F8AQ53509972-48C9C92C-A095-4937-892E-CFD5E3A0626CQ53695989-5ED376B3-B8A5-4816-9851-6C4A420A5398Q54766883-C2DDD5F9-7DCA-413B-95DE-84E80FC4E8CD
P2860
Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Serum levels of autoantibodies ...... n systemic lupus erythematosus
@ast
Serum levels of autoantibodies ...... n systemic lupus erythematosus
@en
Serum levels of autoantibodies ...... n systemic lupus erythematosus
@nl
type
label
Serum levels of autoantibodies ...... n systemic lupus erythematosus
@ast
Serum levels of autoantibodies ...... n systemic lupus erythematosus
@en
Serum levels of autoantibodies ...... n systemic lupus erythematosus
@nl
prefLabel
Serum levels of autoantibodies ...... n systemic lupus erythematosus
@ast
Serum levels of autoantibodies ...... n systemic lupus erythematosus
@en
Serum levels of autoantibodies ...... n systemic lupus erythematosus
@nl
P2860
P356
P1476
Serum levels of autoantibodies ...... n systemic lupus erythematosus
@en
P2093
Anders A Bengtsson
Gunnar Sturfelt
P2860
P2888
P304
P356
10.1186/AR1032
P407
P577
2003-12-05T00:00:00Z
P5875
P6179
1008492433